Holly Nadorlik, DO

Publications:
Nadorlik H, Stiver C, Khan S, Miao Y, Holzer R, Cheatham J, Cua C. Correlations between Echocardiographic Systolic and Diastolic Function with Cardiac Catheterization in Biventricular Congenital Heart Patients. Manuscript accepted for publication to Pediatric Cardiology October 2015.
Khan S, Nadorlik H, Kertesz N, Nicholson L, Ro P, Cua C. QRS Duration Changes in Patients with Single Ventricle Physiology: Birth to 10 Years. Manuscript accepted for publication to Pacing and Clinical Electrophysiology June 2015.
Koenig S, Bosse K, Nadorlik H, Lilly B, Garg V. Evidence of Aortopathy in Mice with Haploinsufficiency of Notch1in Nos3-null Background. J Cardiovasc Dev Dis 2015; 2: 17-30.
Stiver C, Nadorlik H, Janevski I, Belfrage K, Wheller J, Cua C. Diastolic Dyssynchrony Differences in Patients with Single Right Ventricles Versus Control Patients. Congenit Heart Dis 2015; 10: 326-332.
Nadorlik H, Fleishman C, Brown D, Miller-Tate H, Lenahan P, Nicholson L, Wheller J, Cua C. Survey of How Pediatric Cardiologists Non-Invasively Evaluate Patients with Hypoplastic Left Heart Syndrome. Congenit Heart Dis 2014; 10: 73-82.
Nadorlik H, Egan M, Hill S, Cheatham J, Galantowicz M, Kovalchin J. Predictors of Ductus Arteriosus In-stent Stenosis in the Hybrid Approach to Hypoplastic Left Heart Syndrome. Pediatr Cardiol 2012; 3: 656-60.
Nadorlik H, Marcon M, Koranyi K, Ramilo O, Mejias A. A 2-month-old with Bacteremia and Gastroenteritis. Pediatr Infect Dis J. 2012; 31: 210-216.

Certifications

Pediatrics
Pediatrics - Pediatric Cardiology

Specialty Interests

Cardiology, Non-invasive Cardiology, Fetal Cardiology

Awards & Honors

Young Alumna of the Year, St. Francis University July 2015
Kinder Key Endowed Cardiology fellow, Nationwide Children's Hospital 2014-2015

Memberships

American College of Cardiology
American Heart Association
American Society of Echocardiography
American Academy of Pediatrics
Society of Pediatric Echocardiography

Research & Publications

See publications for Holly Nadorlik, DO.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 10/27/2023, Dr. Nadorlik has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Coming to a Cleveland Clinic location?

Primary Location

Cleveland Clinic Main Campus

Additional Locations

Treatment & Services

Specialty in Diseases & Conditions

Insurance

Is Cleveland Clinic Part of Your Insurance?

Education & Professional Highlights

Education & Fellowships

Additional Training

Professional Highlights